{
    "id": 30107,
    "fullName": "BARD1 V767fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "BARD1 V767fs results in a change in the amino acid sequence of the Bard1 protein beginning at aa 767 of 777, likely resulting in premature truncation of the functional protein (UniProt.org). V767fs is predicted to confer a loss of function on the Bard1 protein as demonstrated by decreased homology-directed DNA repair activity in cell culture (PMID: 30925164).",
            "references": [
                {
                    "id": 15023,
                    "pubMedId": 30925164,
                    "title": "Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30925164"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 580,
        "geneSymbol": "BARD1",
        "terms": [
            "BARD1"
        ]
    },
    "variant": "V767fs",
    "createDate": "05/07/2019",
    "updateDate": "12/30/2019",
    "referenceTranscriptCoordinates": {
        "id": 179565,
        "transcript": "NM_000465",
        "gDna": "chr2:g.(214728711_214728712)",
        "cDna": "c.(2299_2298)",
        "protein": "p.V767fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16904,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cisplatin treatment of HeLa cells expressing Bard1 P707S were more sensitive than wild-type Bard1 expressing cells, as demonstrated by decreased colony formation (PMID: 30925164).",
            "molecularProfile": {
                "id": 32221,
                "profileName": "BARD1 V767fs"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 4362,
                "name": "cervical cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 15023,
                    "pubMedId": 30925164,
                    "title": "Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30925164"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32221,
            "profileName": "BARD1 V767fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 179565,
            "transcript": "NM_000465",
            "gDna": "chr2:g.(214728711_214728712)",
            "cDna": "c.(2299_2298)",
            "protein": "p.V767fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}